Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Obesity phenotyping matches patients with more effective interventions
Key clinical point: Obesity phenotyping matched patients to a more effective, personalized weight-loss drug intervention.
Major finding: The rate of greater than 10% weight loss after 1 year was 79% with phenotype-guided treatment and 35% without.
Study details: A single-center, prospective, randomized study.
Disclosures: The study received no commercial funding. Dr. Acosta is a consultant to Rhythm Pharmaceuticals and General Mills and has received research support from Novo Nordisk, Rhythm Pharmaceuticals, Satiogen, and Vivus. Dr. Clark had no disclosures.
Citation:
Acosta AJ. Obesity Week 2020.